Home > Products > Biosimilars

BioSIM anti-Human IL-31Ra Antibody (Nemolizumab Biosimilar), Research Grade

Catalog: SIM0510
Cost advantage to: SIM0078
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic biosimilar shares the same variable regions as therapeutic Nemolizumab (a humanized IgG2 mAb targeting IL-31RA), ideal for research. IL-31RA mediates IL-31’s effects (pruritus, inflammation, etc.). Nemolizumab blocks IL-31 signaling, interrupts itch-scratch cycles in AD/PN, and relieves pruritus clinically. The biosimilar suits studying IL-31 signaling, neuroimmune interactions, and anti-pruritic therapeutics development.
 

Specifications

Product Name BioSIM anti-Human IL-31Ra Antibody (Nemolizumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype /
Target IL-31Ra
Other Names CIM331, CAS: 1476039-58-3, Nemoliz​umab
CAS 1476039-58-3
Reactivity Human
Host Species Humanized
Background This non-therapeutic biosimilar shares the same variable regions as therapeutic Nemolizumab (a humanized IgG2 mAb targeting IL-31RA), ideal for research. IL-31RA mediates IL-31’s effects (pruritus, inflammation, etc.). Nemolizumab blocks IL-31 signaling, interrupts itch-scratch cycles in AD/PN, and relieves pruritus clinically. The biosimilar suits studying IL-31 signaling, neuroimmune interactions, and anti-pruritic therapeutics development.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products